Dermatological Malignancies | Norton Healthcare

Indication: Dermatological Malignancies

PVSRIPO with and without Immune Checkpoint Blockade in Advanced PD-1Refractory Melanoma

Sub-indication: Melanoma

Drug Study

Principal Investigator: Jaspreet Grewal, M.D.
Norton Cancer Institute

Sponsor: Istari Oncology

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.